Application of d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) in transdermal and topical drug delivery systems (TDDS)

被引：31
|
作者：
Pham C.V. [1 ]
Cho C.-W. [1 ]
机构：
[1] College of Pharmacy, Chungnam National University, 99 Daehak-ro, Yuseong-gu, Daejeon
来源：
Journal of Pharmaceutical Investigation | 2017年 / 47卷 / 2期
关键词：
Solubilizer; Topical; TPGS; Transdermal;
D O I：
10.1007/s40005-016-0300-x
中图分类号：
学科分类号：
摘要：
d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) is a water-soluble nonionic surfactant, which is prepared from the esterification of Vitamin E succinate with polyethylene glycol 1000. Due to unique amphiphilic structure, TPGS offers many essential properties such as solubilizer, penetration enhancer, stabilizer, emulsifier, antioxidant agent and protection of drug in micelles, which can be used for permeation of drug through skin or deposition of drug in skin. Especially, the applications of TPGS for various systems such as supersaturated system, solid lipid nanoparticles, gels, microemulsions, nanoemulsions and solid dispersions will be discussed in this review. © 2017, The Korean Society of Pharmaceutical Sciences and Technology.
引用
收藏
页码：111 / 121
页数：10
相关论文
共 50 条
  • [1] Effect of D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) on surfactant monolayers
    Shah, Apurva R.
    Banerjee, R.
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2011, 85 (02) : 116 - 124
  • [2] Inhibition of P-glycoprotein by D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS)
    Dintaman, JM
    Silverman, JA
    PHARMACEUTICAL RESEARCH, 1999, 16 (10) : 1550 - 1556
  • [3] Inhibition of P-Glycoprotein by D-α-Tocopheryl Polyethylene Glycol 1000 Succinate (TPGS)
    Jay M. Dintaman
    Jeffrey A. Silverman
    Pharmaceutical Research, 1999, 16 : 1550 - 1556
  • [4] D-α-Tocopheryl polyethylene glycol 1000 succinate (TPGS) modified poly(L-lactide) (PLLA) films for localized delivery of paclitaxel
    Dong, Yuancai
    Zhang, Zhiping
    Feng, Si-Shen
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 350 (1-2) : 166 - 171
  • [5] On the combined use of cyclodextrins and D-α-tocopheryl polyethylene glycol succinate as a drug delivery system
    Gonzalez-Gaitano, Gustavo
    Dreiss, Cecile
    Puig, Joan
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [6] Doxorubicin conjugated to D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS):: Conjugation chemistry, characterization, in vitro and in vivo evaluation
    Cao, Na
    Feng, Si-Shen
    BIOMATERIALS, 2008, 29 (28) : 3856 - 3865
  • [7] Physical characterizations of microemulsion systems using tocopheryl polyethylene glycol 1000 succinate (TPGS) as a surfactant for the oral delivery of protein drugs
    Ke, WT
    Lin, SY
    Ho, HO
    Sheu, MT
    JOURNAL OF CONTROLLED RELEASE, 2005, 102 (02) : 489 - 507
  • [8] Vitamin E D-α-tocopheryl polyethylene glycol 1000 succinate-based nanomedicine
    Zhang, Zhiping
    Mei, Lin
    Feng, Si-Shen
    NANOMEDICINE, 2012, 7 (11) : 1645 - 1647
  • [9] D-α-tocopheryl polyethylene glycol 1000 succinate functionalized nanographene oxide for cancer therapy
    de Melo-Diogo, Duarte
    Pais-Silva, Cleide
    Costa, Elisabete C.
    Louro, Ricardo O.
    Correia, Ilidio J.
    NANOMEDICINE, 2017, 12 (05) : 443 - 456
  • [10] Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance
    Hao, Tangna
    Chen, Dawei
    Liu, Kexin
    Qi, Yan
    Tian, Yan
    Sun, Pengyuan
    Liu, Yuanhong
    Li, Zhen
    ACS APPLIED MATERIALS & INTERFACES, 2015, 7 (32) : 18064 - 18075
12345